HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Cerebral hyponatremia — Clinical Guidelines

Overview

Hyponatremia, defined as a serum sodium concentration <135 mmol/L, is the most common electrolyte disorder encountered in clinical practice, often associated with adverse outcomes including cognitive impairment, falls, and increased mortality 1 11 13.

Diagnosis

Clinical Presentation: Symptoms range from subtle to severe, including confusion, seizures, and coma 1 11.

Laboratory Tests: Serum sodium levels, osmolality, urine osmolality, and urine sodium concentration 1 11.

Differential Diagnosis: Rule out pseudohyponatremia due to hyperproteinemia or hyperlipidaemia 15.

Causes Identification: Evaluate for SIADH, diuretic use, hypothyroidism, liver disease, and medications 1 19 28.

Management

Gradual Correction: For chronic hyponatremia, correct serum sodium by ≤10 mmol/L/day to avoid osmotic demyelination syndrome 1 11.

Acute Severe Hyponatremia: Rapid correction with hypertonic saline (e.g., 3% NaCl) may be necessary, guided by clinical status 4 11.

Drug Therapy: Vaptans (e.g., tolvaptan) for SIADH, targeting vasopressin receptors 20 13.

Fluid Restriction: Essential in managing fluid overload 1 11.

Special Populations

Elderly: Higher prevalence and risk of adverse outcomes; careful monitoring and management crucial 3 10 28.

Comorbidities: Consider underlying conditions like liver disease, heart failure, and malignancies affecting fluid balance 1 19.

Key Recommendations

Rapid Correction of Severe Hyponatremia: Use hypertonic saline for severe symptomatic hyponatremia, guided by clinical response (Evidence: Moderate) 4.

Gradual Correction for Chronic Hyponatremia: Limit daily increase in serum sodium to ≤10 mmol/L to prevent osmotic demyelination syndrome (Evidence: Strong) 1 11.

Use of Vaptans in SIADH: Consider arginine vasopressin receptor antagonists like tolvaptan for managing SIADH (Evidence: Moderate) 20 13.

Monitoring in Elderly Patients: Closely monitor elderly patients due to higher risk of complications (Evidence: Expert opinion) 3 10 28.

Identify and Address Underlying Causes: Thorough evaluation and management of underlying causes such as medications and endocrine disorders (Evidence: Moderate) 1 19 28.

References

1 Judson TJ, Lo L, Demko JE, Mourad M, Liu KD, Wachter RM et al.. Addressing Inpatient Hyponatremia Through Targeted Automatic E-consults: A Pilot Randomized Trial. Journal of general internal medicine 2025. link 2 Waller M, Barkley S, Harrison T. Can introducing a direct endocrine pathway reduce hyponatraemia in elective knee and hip replacements? A closed-loop audit and service evaluation study. Annals of the Royal College of Surgeons of England 2025. link 3 van Orten-Luiten ACB, Brouwer-Brolsma EM, Janse A, Witkamp RF. A drug-based model to predict hyponatremia in outpatients of a geriatric clinic. European journal of clinical pharmacology 2025. link 4 Arshad MF, Iqbal A. Use of hypertonic saline in severe symptomatic hyponatraemia; results from a national survey of endocrinologists in the United Kingdom. Endocrine 2024. link 5 Estévez Asensio L, García M, Verde Rello Z, Velasco-González V, Fernández-Araque AM, Sainz-Gil M. Drug-induced hyponatraemia and possible related signals: Analysis of 659 cases reported to the Spanish Pharmacovigilance System and disproportionality analysis. Medicina clinica 2024. link 6 Verano ND. The Nephrology Nurse Practitioner's Diagnostic Guide to Hyponatremia. Nephrology nursing journal : journal of the American Nephrology Nurses' Association 2023. link 7 Lee Y, Yoo KD, Baek SH, Kim YG, Kim HJ, Ryu JY et al.. Korean Society of Nephrology 2022 recommendations on controversial issues in diagnosis and management of hyponatremia. The Korean journal of internal medicine 2022. link 8 de Canecaude C, Rousseau V, Chebane L, Lafaurie M, Durrieu G, Montastruc JL. Can tramadol really induce hyponatraemia? A pharmacovigilance study. British journal of clinical pharmacology 2021. link 9 Brinkkoetter PT, Grundmann F, Ghassabeh PJ, Becker I, Johnsen M, Suaréz V et al.. Impact of Resolution of Hyponatremia on Neurocognitive and Motor Performance in Geriatric Patients. Scientific reports 2019. link 10 Grattagliano I, Mastronuzzi T, D'Ambrosio G. Hyponatremia associated with long-term medication use in the elderly: an analysis in general practice. Journal of primary health care 2018. link 11 Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D et al.. Clinical practice guideline on diagnosis and treatment of hyponatraemia. European journal of endocrinology 2014. link 12 Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D et al.. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2014. link 13 Peri A. Clinical review: the use of vaptans in clinical endocrinology. The Journal of clinical endocrinology and metabolism 2013. link 14 Mannesse CK, Vondeling AM, van Marum RJ, van Solinge WW, Egberts TC, Jansen PA. Prevalence of hyponatremia on geriatric wards compared to other settings over four decades: a systematic review. Ageing research reviews 2013. link 15 Fortgens P, Pillay TS. Pseudohyponatremia revisited: a modern-day pitfall. Archives of pathology & laboratory medicine 2011. link 16 Beers E, van Puijenbroek EP, Bartelink IH, van der Linden CM, Jansen PA. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) or hyponatraemia associated with valproic Acid: four case reports from the Netherlands and a case/non-case analysis of vigibase. Drug safety 2010. link 17 Marcialis MA, Dessì A, Contu S, Fanos V. Nephrogenic syndrome of inappropriate antidiuresis: a novel cause of euvolemic hypotonic hyponatremia in newborns. Diagnosis and practical management. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2009. link 18 Rogers IR, Hew-Butler T. Exercise-associated hyponatremia: overzealous fluid consumption. Wilderness & environmental medicine 2009. link 19 Liamis G, Milionis H, Elisaf M. A review of drug-induced hyponatremia. American journal of kidney diseases : the official journal of the National Kidney Foundation 2008. link 20 Vachharajani T, Vachharajani V. Vasopressin-receptor antagonist therapy in patients with hyponatraemia. British journal of hospital medicine (London, England : 2005) 2007. link 21 Chorley JN. Hyponatraemia : identification and evaluation in the marathon medical area. Sports medicine (Auckland, N.Z.) 2007. link 22 Chorley J, Cianca J, Divine J. Risk factors for exercise-associated hyponatremia in non-elite marathon runners. Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine 2007. link 23 O'Connor RE. Exercise-induced hyponatremia: causes, risks, prevention, and management. Cleveland Clinic journal of medicine 2006. link 24 Adrogué HJ. Consequences of inadequate management of hyponatremia. American journal of nephrology 2005. link 25 Kluger MT, Szekely SM, Singleton RJ, Helps SC. Crisis management during anaesthesia: water intoxication. Quality & safety in health care 2005. link 26 Atlaoui D, Duclos M, Gouarne C, Lacoste L, Barale F, Chatard JC. The 24-h urinary cortisol/cortisone ratio for monitoring training in elite swimmers. Medicine and science in sports and exercise 2004. link 27 Gross P, Reimann D, Henschkowski J, Damian M. Treatment of severe hyponatremia: conventional and novel aspects. Journal of the American Society of Nephrology : JASN 2001. link 28 Anpalahan M. Chronic idiopathic hyponatremia in older people due to syndrome of inappropriate antidiuretic hormone secretion (SIADH) possibly related to aging. Journal of the American Geriatrics Society 2001. link 29 Troup JP. The physiology and biomechanics of competitive swimming. Clinics in sports medicine 1999. link70143-5) 30 Vanapruks V, Prapaitrakul K. Water intoxication and hyponatraemic convulsions in neonates. Archives of disease in childhood 1989. link 31 Rossi NF, Cadnapaphornchai P. Disordered water metabolism: hyponatremia. Critical care clinics 1987. link 32 Grimston SK, Hay JG. Relationships among anthropometric and stroking characteristics of college swimmers. Medicine and science in sports and exercise 1986. link 33 Lavoie JM, Cousineau D, Péronnet F, Provencher PJ. Metabolic and hormonal responses of elite swimmers during a regular training session. European journal of applied physiology and occupational physiology 1983. link 34 Baxter C, Reilly T. Influence of time of day on all-out swimming. British journal of sports medicine 1983. link 35 Sharp RL, Troup JP, Costill DL. Relationship between power and sprint freestyle swimming. Medicine and science in sports and exercise 1982. link 36 Armstrong N, Davies B. An ergometric analysis of age group swimmers. British journal of sports medicine 1981. link 37 Montpetit RR, Léger LA, Lavoie JM, Cazorla G. VO2 peak during free swimming using the backward extrapolation of the O2 recovery curve. European journal of applied physiology and occupational physiology 1981. link 38 Banister EW, Calvert TW. Planning for future performance: implications for long term training. Canadian journal of applied sport sciences. Journal canadien des sciences appliquees au sport 1980. link 39 Rushall BS, Fox RG. An approach-avoidance motivations scale for sports. Canadian journal of applied sport sciences. Journal canadien des sciences appliquees au sport 1980. link 40 Burrows AW, Gribbin B. Clonidine-induced dilutional hyponatraemia. Postgraduate medical journal 1979. link 41 Jose CJ, Barton JL, Perez-Cruet J. Hyponatremic seizures in psychiatric patients. Biological psychiatry 1979. link 42 Sawka MN, Knowlton RG, Miles DS, Critz JB. Post-competition blood lactate concentrations in collegiate swimmers. European journal of applied physiology and occupational physiology 1979. link 43 Rushall BS, Leet D. The prediction of swimming performance in competition from behavioral information. Canadian journal of applied sport sciences. Journal canadien des sciences appliquees au sport 1979. link 44 Hickson RC, Hagberg JM, Conlee RK, Jones DA, Ehsani AA, Winder WW. Effect of training on hormonal responses to exercise in competitive swimmers. European journal of applied physiology and occupational physiology 1979. link 45 Craig AB, Pendergast DR. Relationships of stroke rate, distance per stroke, and velocity in competitive swimming. Medicine and science in sports 1979. link 46 Sztobryn M, Kuński H. Erythrocyte 2,3-diphosphoglycerate (2,3-DPG) after submaximal exercise in human subjects. Acta physiologica Polonica 1978. link 47 Bagnall KM, Kellett DW. A study of potential Olympic swimmers: I, the starting point. British journal of sports medicine 1977. link

Cerebral hyponatremia